What is SLRX's revenue growth forecast for 2026-2026?
(NASDAQ: SLRX) Salarius Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Salarius Pharmaceuticals's revenue in 2026 is $0.
In 2026, SLRX is forecast to generate $71,008,562 in revenue, with the lowest revenue forecast at $68,224,028 and the highest revenue forecast at $73,095,497.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.